ZA895797B - Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides - Google Patents

Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides

Info

Publication number
ZA895797B
ZA895797B ZA895797A ZA895797A ZA895797B ZA 895797 B ZA895797 B ZA 895797B ZA 895797 A ZA895797 A ZA 895797A ZA 895797 A ZA895797 A ZA 895797A ZA 895797 B ZA895797 B ZA 895797B
Authority
ZA
South Africa
Prior art keywords
thiobenzamides
benzamides
azabicyclo
oct
memory enhancing
Prior art date
Application number
ZA895797A
Other languages
English (en)
Inventor
Robert John Naylor
John Naylor Robert
Brenda Naylor
Naylor Brenda
Alain Renaud
Renaud Alain
Michel Langlois
Langlois Michel
Original Assignee
Robins Co Inc A H
Delalande Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Robins Co Inc A H, Delalande Sa filed Critical Robins Co Inc A H
Publication of ZA895797B publication Critical patent/ZA895797B/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/445—Non condensed piperidines, e.g. piperocaine
    • A61K31/45—Non condensed piperidines, e.g. piperocaine having oxo groups directly attached to the heterocyclic ring, e.g. cycloheximide
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
    • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia

Landscapes

  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Psychiatry (AREA)
  • Hospice & Palliative Care (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
ZA895797A 1988-08-04 1989-07-28 Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides ZA895797B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP88402041A EP0353371A1 (en) 1988-08-04 1988-08-04 Memory enhancing-R-N-(1-azabicyclo[2.2.2] oct-3-yl) benzamides and thiobenzamides

Publications (1)

Publication Number Publication Date
ZA895797B true ZA895797B (en) 1991-03-27

Family

ID=8200414

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA895797A ZA895797B (en) 1988-08-04 1989-07-28 Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides

Country Status (10)

Country Link
US (1) US5017580A (ja)
EP (1) EP0353371A1 (ja)
JP (1) JPH02256616A (ja)
KR (1) KR900002778A (ja)
AU (1) AU624402B2 (ja)
CA (1) CA1333154C (ja)
DK (1) DK381889A (ja)
PH (1) PH25427A (ja)
PT (1) PT91346B (ja)
ZA (1) ZA895797B (ja)

Families Citing this family (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.
EP0527249B1 (en) * 1991-08-09 1997-12-17 Nec Corporation Carrier recovery apparatus for digital satellite communication system
US5273972A (en) * 1992-03-26 1993-12-28 A. H. Robins Company, Incorporated [(2-diakylaminomethyl)-3-quinuclidinyl]-benzamides and benzoates
US5723103A (en) * 1994-12-09 1998-03-03 Vanderbilt University Substituted benzamides and radioligand analogs and methods of use
US6492385B2 (en) 2000-08-18 2002-12-10 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
US6479510B2 (en) 2000-08-18 2002-11-12 Pharmacia & Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002016357A2 (en) * 2000-08-18 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted aryl moieties for treatment of disease (nicotinic acetylcholine receptor ligands)
AU2001284645A1 (en) * 2000-08-18 2002-03-04 Pharmacia And Upjohn Company Quinuclidine-substituted aryl compounds for treatment of disease
WO2002017358A2 (en) 2000-08-21 2002-02-28 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease (nicotinic acetylcholine receptor antagonists)
US6599916B2 (en) 2000-08-21 2003-07-29 Pharmacia & Upjohn Company Quinuclidine-substituted heteroaryl moieties for treatment of disease
PE20021019A1 (es) * 2001-04-19 2002-11-13 Upjohn Co Grupos azabiciclicos sustituidos
EP1419162A1 (en) * 2001-08-24 2004-05-19 Pharmacia & Upjohn Company Substituted-aryl 7-aza 2.2.1]bicycloheptanes for the treatment of disease
AU2002339810A1 (en) * 2001-10-16 2003-04-28 Astrazeneca Ab Azabicyclic compounds for the treatment of fibromyalgia syndrome
US6919359B2 (en) * 2001-11-08 2005-07-19 Pfizer Inc Azabicyclic-substituted-heteroaryl compounds for the treatment of disease
DE10164139A1 (de) 2001-12-27 2003-07-10 Bayer Ag 2-Heteroarylcarbonsäureamide
BR0307714A (pt) * 2002-02-15 2005-02-09 Upjohn Co Benzoilamidas substituìdas com azabiciclo e tioamidas para tratamento de distúrbios relacionados ao cns
US7001900B2 (en) 2002-02-20 2006-02-21 Pfizer Inc. Azabicyclic compounds for the treatment of disease
EP1542999A1 (en) 2002-08-01 2005-06-22 Pharmacia & Upjohn Company LLC 1h-pyrazole and 1h-pyrrole-azabicyclic compounds with alfa-7 nachr activity
GB0310867D0 (en) 2003-05-12 2003-06-18 Novartis Ag Organic compounds
EP2344636B1 (en) 2008-10-09 2017-12-06 Howard Hughes Medical Institute Novel chimeric ligand-gated ion channels and methods of use thereof
ES2541528T3 (es) 2008-11-19 2015-07-21 Forum Pharmaceuticals Inc. Tratamiento de trastornos cognitivos con (R)-7-cloro-N-(quinuclidin-3-il)benzo[b]tiofeno-2-carboxamida y sales farmacéuticamente aceptables de la misma
SI3029039T1 (en) 2010-05-17 2018-04-30 Forum Pharmaceuticals Inc. Pharmaceutical formulations containing crystalline forms of (R) -7-chloro-N- (quinuclidin-3-yl) benzo (b) thiophene-2-carboxamide hydrochloride monohydrate
WO2013169646A1 (en) 2012-05-08 2013-11-14 Envivo Pharmaceuticals, Inc. Methods of maintaining, treating or improving cognitive function
CN104418851A (zh) * 2013-09-02 2015-03-18 上海龙翔生物医药开发有限公司 奎宁环衍生物的制备方法及纯化方法
US10370369B2 (en) * 2015-03-31 2019-08-06 Yuki Gosei Kogyo Co. Ltd. Acid addition salt of 3-aminoquinuclidine which does not exhibit deliquescence

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4605652A (en) * 1985-02-04 1986-08-12 A. H. Robins Company, Inc. Method of enhancing memory or correcting memory deficiency with arylamido (and arylthioamido)-azabicycloalkanes
DE3878235T2 (de) * 1988-08-04 1993-06-03 Synthelabo Antischizophren-wirksame s-n-(1-azabicyclo (2.2.2.)oct-3-yl)benzamide und thiobenzamide.

Also Published As

Publication number Publication date
KR900002778A (ko) 1990-03-23
US5017580A (en) 1991-05-21
EP0353371A1 (en) 1990-02-07
AU624402B2 (en) 1992-06-11
PT91346B (pt) 1995-07-03
PT91346A (pt) 1990-03-08
AU3917489A (en) 1990-02-08
CA1333154C (en) 1994-11-22
DK381889A (da) 1990-02-05
JPH02256616A (ja) 1990-10-17
DK381889D0 (da) 1989-08-03
PH25427A (en) 1991-07-01

Similar Documents

Publication Publication Date Title
ZA895797B (en) Memory enhancing-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides
PH23937A (en) Anxiolytic-n-(1-azabicyclo(2.2.2.)oct-3-yl)benzamides and thiobenzamides
GB2225940B (en) Center fold play yard
GB2159516B (en) Azaphthalocyanines and their use as photoactivators
GB8819307D0 (en) Antiarrhythmic agents
ZA895005B (en) Azacyclic compounds and their preparation and use
ZA887601B (en) Anxiolytic-r-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides
GB2225240B (en) Play surfaces
JPS6463573A (en) Antiarrhythmic 1h-pyrazole-1-alkaneamide and manufacture
NZ229274A (en) 1,2-dithiol-3-thion-s-oxides and liver-protective medicaments
ZA879417B (en) Anxiolytic-n-(1-azabicyclo(2.2.2)oct-3-yl)benzamides and thiobenzamides
GB8807266D0 (en) Information storage
JPS646223A (en) Perfluoro-2,3,4-trimethylpentane and manufacture
EP0172233A4 (en) PUNAGLANDINS AND THEIR PHARMACEUTICAL USE.
GR890100675A (en) Aryloxyaldehydes and their manufacture
IE892440L (en) Antischizophrenic-s-n-(1-azabicyclo£2.2.2|oct-3-yl)¹benzamides and thiobenzamides
IE883128L (en) 1-azabicyclo (2.2.2) oct-3-yl derivatives
Rosenbaum Who Framed Roger Rabbit?
Hennessy Technology and Modernism
ZA897772B (en) Organotinfluorides and their manufacture
Sherry Poetic Development
GB2150134B (en) Pharmaceutically active 1,1-diphenyl-4-isobutylamino-1-1butanol and derivatives thereof
IE873403L (en) Anxiolytic-n-(1-azabicyclo £2,2,2| oct-3-yl) benzamides and¹thiobenzamides
GB8800749D0 (en) Memory game
JPS6425789A (en) Substituted amidephophonate and amidephosphate